Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL01653	盐酸托泊替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs(4)	New Drug Application	2001-07-30	史克必成（天津）有限公司	Glaxo Smith Kline Tianjin Co Ltd			view
CXL01652	盐酸托泊替康胶囊	topotecan hydrochloride	Capsule	Chemical Drugs(4)	New Drug Application	2001-07-30	史克必成（天津）有限公司	Glaxo Smith Kline Tianjin Co Ltd	Certificate Issued	2002-02-26	view
A20010039	甲磺酸吉米沙星	Gemifloxacin Mesylate	Active ingredient	Chemical Drugs	Import Drug Application	2001-05-11	史克必成（天津）有限公司	Glaxo Smith Kline Tianjin Co Ltd	Approval Completed-Pending Certificated	2002-01-23	view
H19990059	阿莫西林/克拉维酸钾干混悬剂	amoxicillin;potassium clavulanate	Suspension	Chemical Drugs	Import Drug Application	2000-01-01	史克必成（天津）有限公司北京办事处		Approval Completed-Pending Certificated	2000-09-30	view